Another mechanism that impairs the antiproliferative effects of the TGF-β pathway in HCC is based on tristetraprolin (TTP), a negative post-transcriptional regulator of c-Myc with downregulated expression in HCC tumor tissues. Here, MYC is linked to hepatocellular carcinoma.